Treatment of refractory hematologic malignancies by combination of cytarabine ocfosfate and etoposide

Japanese Journal of Cancer and Chemotherapy

Volumn 23, Issue 12, 1996, Pages 1717-1720

  Kiyama, Y ^a   Suzuki, G ^a   Masauzi, N ^a   Ohizumi, H ^a   Kobayashi, N ^a   Ogasawara, M ^a   Naohara, T ^a   Saito, M ^a   Higa, T ^a   Kasai, M ^a  

^a SAPPORO HOKUYU HOSPITAL   (Japan)

Author keywords

Acute non lymphocytic leukemia; Cytarabine ocfosfate; Etoposide; Myelodysplastic syndrome

Indexed keywords

CYTARABINE 5' STEARYLPHOSPHATE; ETOPOSIDE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CONCENTRATION RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHATIC LEUKEMIA; MALE; MYELODYSPLASTIC SYNDROME; REMISSION; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARABINONUCLEOTIDES; CYTIDINE MONOPHOSPHATE; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; HUMANS; LEUKEMIA; MALE; MIDDLE AGED;

EID: 0029830846     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)